Neuronet (Efficiently Networking European Neurodegeneration Research, https://www.imi-neuronet.org/) just launched a new version of their Decision Tool to support engagement with Regulatory and Health Technology Assessment (HTA) bodies. The Decision Tool provides a clickable overview of the processes and procedures for HTA and regulatory interactions at different stages of the development pipeline to help ensure that the outputs being developed by Innovative Medicines Initiative research projects are relevant for regulatory and HTA settings, where applicable. Neuronet, a Coordination and Support Action [...]